Bruna Pellini

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Bruna Pellini
Dec 30, 2024, 00:53 | Science
Marco Donia about the FDA approved nivolumab across solid tumors
Marco Donia, Senior Consultant at the University of Copenhagen Herlev Hospital, shared a recent article…
Dec 23, 2024, 12:19 | Science
Anirban Maitra: Preclinical data on potential combination to overcome KRASi resistance
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center,…
Dec 19, 2024, 11:54 | Opinion
Lung Cancer Trial Highlights from 2024 By Yakup Ergün
Yakup Ergün, Medical Oncologist at Antalya City Hospital, posted on X: “What happened in Lung…
Dec 2, 2024, 09:46 | Positive
Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
As November came to a close, it's an ideal time to reflect on Lung Cancer…
Nov 27, 2024, 12:54 | Blog
Christian Rolfo: Challenges in technology validation and access around the world by Ola Khorsid at ISLB24
Christian Rolfo, Division Director of Medical Oncology and Associate Director for Early Phase Clinical Trials…
Nov 26, 2024, 12:12 | Insight
Highlights from ISLB 2024: Exploring the Future of Liquid Biopsy
The 6th Annual Congress of the International Society of Liquid Biopsy (ISLB) took place in…
Nov 7, 2024, 13:12 | Insight
Bruna Pellini: Are all immune checkpoint inhibitors the same?
Bruna Pellini, Assistant Professor at the University of South Florida shared her recent article on…
Oct 17, 2024, 14:53 | Blog
Bruna Pellini: Let’s debunk some of the common lung cancer myths and misconceptions I hear in the clinic!
Bruna Pellini posted on LinkedIn: "Let’s debunk some of the common lung cancer myths and…
Oct 10, 2024, 18:03 | Insight
Meet Bruna Pellini at ISLB24
International Society of Liquid Biopsy shared on X: “Meet Bruna Pellini at ISLB24! Bruna Pellini…
Sep 10, 2024, 17:17 | Blog
Bruna Pellini: Why should we study circulating tumor DNA
Bruna Pellini shared a post on LinkedIn: "Why should we study circulating tumor DNA (ctDNA)?…
Sep 7, 2024, 09:56 | Blog
Bruna Pellini: Why should we study circulating tumor DNA?
Bruna Pellini, Assistant Member and Thoracic Oncologist at Moffitt Cancer Center and Co-Chair at NIH,…
Jul 16, 2024, 15:43 | Blog
Bruna Pellini will present at the MD Anderson Cancer Center General Oncology Grand Rounds
Bruna Pellini, Assistant Member and Thoracic Oncologist at Moffitt Cancer Center and Co-Chair at NIH,…
Jul 13, 2024, 06:53 | Blog
Luis Raez: 2024 Memorial Cancer Institute Best of ASCO
Luis Raez, Medical Director at Memorial Cancer Institute, shared a post on LinkedIn:     …
Jul 10, 2024, 00:57 | Blog
Pre-analytical phase challenges and biomarker testing in lung cancer - Precision Oncology CONNECT
Precision Oncology CONNECT shared a post on X: ''Do you understand the specific biomarkers detected by…
Jul 8, 2024, 09:42 | Blog
Gerard Walls: ctDNA, a future tool for radiation therapy personalization in lung cancer?
Gerard Walls, Lung Cancer Clinical Fellow at The Christie NHS Foundation Trust, shared a thread…
Jul 1, 2024, 17:09 | Blog
Patrick Hwu: ctDNA testing, cancer screening and treatment
Patrick Hwu shared a post LinkedIn: “How are we using ctDNA testing, also called liquid…
Jun 6, 2024, 11:15 | Societies
Patrick Hwu: Thank you Bruna Pellini for sharing your perspective on this practice-changing work
Patrick Hwu recently shared a post by the Moffitt Cancer Center on X, adding: "Such…
Apr 27, 2024, 11:47 | Blog
Dive deep into the world of lung cancer biomarker testing with Bruna Pellini and Semir Vranić - Precision Oncology CONNECT
Precision Oncology CONNECT shared a post on LinkedIn: “Dive deep into the world of lung…
All: 18 Posts: 1 - 100
Special Coverage